Filing Flows › LifeStance Health Group (LFST) › Q2 2026 › vs Q1 2026
LifeStance Health Group (LFST) Q2 2026 vs Q1 2026 (quarter over quarter)
LifeStance Health Group's revenue rose $31.9M (+8%) from $403M in Q1 2026 to $435M in Q2 2026. Operating margin 7.0% against 5.5% (+1.5 pts).
LifeStance Health Group, Q2 2026: revenue $435M (+26% year over year), operating margin 7.0%, net earnings $23.6M, operating cash flow $99.9M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 7.0% | 5.5% | +1.5 pts |
| Net margin | 5.4% | 3.5% | +1.9 pts |
| Free cash flow margin | 20.2% | 5.5% | +14.7 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $435M | $403M | $31.9M | +8% |
| Operating profit | $30.7M | $22.3M | $8.4M | +38% |
| Costs & expenses | $405M | $381M | $23.5M | +6% |
| Pre-tax earnings | $27.5M | $19.8M | $7.7M | +39% |
| Other expense, net | $3.2M | $2.5M | $672K | +27% |
| SG&A | $108M | $100M | $7.8M | +8% |
| Other operating costs | $297M | $281M | $15.7M | +6% |
| Net earnings | $23.6M | $14.2M | $9.4M | +66% |
| Income tax | $3.8M | $5.5M | −$1.7M | -30% |
| Depreciation & amortization | $11.3M | $10.4M | $943K | +9% |
| Share-based compensation | $19.7M | $15.2M | $4.5M | +30% |
| Working capital & other | $45.2M | −$6.7M | $51.9M | — |
| Operating cash flow | $99.9M | $33.1M | $66.8M | +202% |
| Free cash flow (OCF − capex) | $87.9M | $22.3M | $65.6M | +294% |
| Capital expenditures | $12.0M | $10.8M | $1.2M | +11% |
Questions
How much did LifeStance Health Group's revenue grow quarter over quarter in Q2 2026?
LifeStance Health Group's revenue rose $31.9M (+8%) from $403M in Q1 2026 to $435M in Q2 2026. Operating margin 7.0% against 5.5% (+1.5 pts).